Interventions for opioid use disorder during pregnancy: a scoping review - Scorecard - MDSpire

Interventions for opioid use disorder during pregnancy: a scoping review

  • By

  • Amanda L. Elmore

  • Mirine Richey

  • Dewan S. Tahsin

  • Gabriella Hinks

  • William Velez-Jimenez

  • Allison M. Howard

  • Tanner Wright

  • Anthony Kendle

  • Cheryl Vamos

  • April 1, 2026

  • 0 min

Share

Clinical Scorecard: Strategies for Managing Opioid Use Disorder in Pregnant Individuals: A Scoping Review

At a Glance

CategoryDetail
ConditionOpioid Use Disorder (OUD) during pregnancy
Key MechanismsMedication for opioid use disorder (MOUD) combined with behavioral therapies and community/societal interventions
Target PopulationPregnant individuals with opioid use disorder in the United States
Care SettingPrenatal clinical care, interpersonal support settings, community and societal levels

Key Highlights

  • MOUD adherence reduces maternal overdose risk and improves maternal and infant health outcomes.
  • Interventions span individual (clinical care, detoxification, education), interpersonal (clinician education, group therapy), and community/societal levels (service coordination, policy impact).
  • Community-based and societal interventions addressing social determinants and policy barriers may have the greatest impact on maternal health outcomes.

Guideline-Based Recommendations

Diagnosis

  • Identify OUD during pregnancy through screening in prenatal care settings.

Management

  • Implement evidence-based MOUD (buprenorphine or methadone) combined with behavioral therapies.
  • Provide coordinated clinical care models and prenatal education.
  • Incorporate clinician education and group therapy at the interpersonal level.
  • Support regional coordination of services and policy changes to improve MOUD access.

Monitoring & Follow-up

  • Monitor adherence to MOUD and engagement with behavioral therapies throughout pregnancy.
  • Assess social and financial support needs to foster mother-infant wellness beyond pregnancy.

Risks

  • Barriers to MOUD access and long-term adherence remain significant challenges.
  • Non-prescription substance use postpartum is common, especially with prenatal stressful life events.

Patient & Prescribing Data

Pregnant people with opioid use disorder, predominantly non-Hispanic white participants in many studies.

MOUD access and adherence are critical; interventions must address social determinants and systemic barriers to improve outcomes.

Clinical Best Practices

  • Use pregnancy as an opportunity to initiate and maintain MOUD and behavioral therapies.
  • Employ multi-level interventions addressing individual, interpersonal, community, and societal factors.
  • Integrate education for clinicians and patients to improve treatment uptake and retention.
  • Coordinate services regionally to enhance access and continuity of care.
  • Advocate for policy changes that reduce barriers to MOUD during pregnancy.

References

Original Source(s)

Related Content